Home » Topics » BioWorld Science

BioWorld Science
RSS

New AXL/c-Met inhibitors disclosed by Shanghai Institute of Materia Medica

Dec. 16, 2019

Decoding EGFR's skin toxicity

Dec. 16, 2019

Beijing Innocare Pharmaceutical Technology discovers IDO-1 inhibitors

Dec. 16, 2019

Shanghai Zhimeng Biopharma describes potassium channel activators

Dec. 16, 2019

Unexpected Ibrance MOA

Dec. 16, 2019

GDF1 unveiled as a therapeutic target for treating AML

Dec. 16, 2019

Blood-brain barrier disruption could be Alzheimer's target

Dec. 16, 2019

Cirmtuzumab plus paclitaxel safe and well-tolerated in phase I study in breast cancer

Dec. 16, 2019

ARX-788 well-tolerated in phase I study in Chinese patients with metastatic HER2+ breast cancer

Dec. 16, 2019

Results reported from ongoing phase I study of FT-4202

Dec. 16, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...